Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Visualization of neurofibrillary tangle maturity in Alzheimer's disease: A clinicopathologic perspective for biomarker research
Christina M. Moloney, Val J. Lowe, Melissa E. Murray
Alzheimer s & Dementia (2021) Vol. 17, Iss. 9, pp. 1554-1574
Open Access | Times Cited: 195

Showing 1-25 of 195 citing articles:

Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials
Rik Ossenkoppele, Rik van der Kant, Oskar Hansson
The Lancet Neurology (2022) Vol. 21, Iss. 8, pp. 726-734
Open Access | Times Cited: 282
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2381-2387
Open Access | Times Cited: 261
Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer’s disease
Marcos Otero-García, Sameehan Mahajani, Debia Wakhloo, et al.
Neuron (2022) Vol. 110, Iss. 18, pp. 2929-2948.e8
Open Access | Times Cited: 119
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Fernándo González‐Ortiz, Przemysław R. Kac, Wagner S. Brum, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 113
Retinal pathological features and proteome signatures of Alzheimer’s disease
Yosef Koronyo, Altan Rentsendorj, Nazanin Mirzaei, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 4, pp. 409-438
Open Access | Times Cited: 83
The role of inflammasomes in human diseases and their potential as therapeutic targets
Jing Yao, Keenan Sterling, Zhe Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 66
Nigrostriatal tau pathology in parkinsonism and Parkinson’s disease
Yaping Chu, Warren D. Hirst, Howard J. Federoff, et al.
Brain (2023) Vol. 147, Iss. 2, pp. 444-457
Open Access | Times Cited: 44
Pathogenesis, Diagnostics, and Therapeutics for Alzheimer's Disease: Breaking the Memory Barrier
Pushpa Tryphena Kamatham, Rashi K. Shukla, Dharmendra Kumar Khatri, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102481-102481
Open Access | Times Cited: 18
Behaviour Hallmarks in Alzheimer’s Disease 5xFAD Mouse Model
Mafalda Soares Pádua, José Luis Guil‐Guerrero, Paula A. Lopes
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6766-6766
Open Access | Times Cited: 17
Evolving therapeutic interventions for the management and treatment of Alzheimer’s disease
Faizan Ahmad, Anik Karan, Rashi Sharma, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102229-102229
Closed Access | Times Cited: 16
Quercetin-functionalized nanomaterials: Innovative therapeutic avenues for Alzheimer's disease management
Jinjin Pei, Ranil Vikraman Kumarasamy, Selvaraj Jayaraman, et al.
Ageing Research Reviews (2025), pp. 102665-102665
Closed Access | Times Cited: 8
Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease
Tohidul Islam, Emily Hill, Eric E. Abrahamson, et al.
Nature Medicine (2025)
Open Access | Times Cited: 5
Linking Oxidative Stress and Proteinopathy in Alzheimer’s Disease
Chanchal Sharma, Sang Ryong Kim
Antioxidants (2021) Vol. 10, Iss. 8, pp. 1231-1231
Open Access | Times Cited: 95
The informed road map to prevention of Alzheimer Disease: A call to arms
Eric McDade, Jorge J. Llibre‐Guerra, David M. Holtzman, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 65
The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death
Dietmar Rudolf Thal, Sandra O. Tomé
Brain Research Bulletin (2022) Vol. 190, pp. 204-217
Open Access | Times Cited: 49
MicroRNA-22-3p ameliorates Alzheimer’s disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus
Pengcheng Xia, Jing Chen, Yingchao Liu, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 46
Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain
Christina M. Moloney, Sydney A. Labuzan, Julia E. Crook, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 3, pp. 1029-1040
Open Access | Times Cited: 42
Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer’s disease, corticobasal degeneration and progressive supranuclear palsy brains
Mona‐Lisa Malarte, Per‐Göran Gillberg, Amit Kumar, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 3, pp. 1272-1283
Open Access | Times Cited: 41
Neurodegenerative Disease Tauopathies
Benjamin C. Creekmore, Ryohei Watanabe, Edward B. Lee
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 19, Iss. 1, pp. 345-370
Open Access | Times Cited: 25
Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease
Shital Rani, Sudhrita Basu Dhar, Akhil Khajuria, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2491-2523
Closed Access | Times Cited: 23
The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges
Huiting Zheng, Huimin Sun, Qixu Cai, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4969-4969
Open Access | Times Cited: 12
The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer’s disease
Marie Sarazin, Julien Lagarde, I. Haddad, et al.
Nature Aging (2024) Vol. 4, Iss. 6, pp. 761-770
Closed Access | Times Cited: 12
Nanoscale imaging of pT217‐tau in aged rhesus macaque entorhinal and dorsolateral prefrontal cortex: Evidence of interneuronal trafficking and early‐stage neurodegeneration
Dibyadeep Datta, Isabella Perone, Denethi Wijegunawardana, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 4, pp. 2843-2860
Open Access | Times Cited: 11
Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status
Haoshen Shi, Nazanin Mirzaei, Yosef Koronyo, et al.
Acta Neuropathologica (2024) Vol. 148, Iss. 1
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top